The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Ubigene Biosciences
New York, United States
B
51-100 Employees
-
Key takeaway
Ubigene is dedicated to making genome editing easier, offering advanced gene-editing services and products. Their innovative CRISPR-U™ technology significantly enhances gene-editing efficiency, and they provide a comprehensive automated design system that supports researchers in this field.
Reference
Service
| Ubigene
Inscripta
Boulder, United States
B
101-250 Employees
2015
Key takeaway
The company highlights its innovative approach to gene editing through methods like CRISPR and Directed Evolution, which enhance biomanufacturing and enable the discovery of beneficial genetic changes. Their digital genome engineering tools promise to transform various fields, including material production, agriculture, and disease treatment.
Reference
Product
Genome Editing - Inscripta®
Our revolutionary digital genome engineering tools transform how we face complex global challenges and yield solutions that benefit all.
Scribe Therapeutics
United States
B
11-50 Employees
2017
Key takeaway
The company is focused on advancing gene editing through innovative delivery technologies that enhance in vivo genetic medicine. Their approach emphasizes precision targeting within the genome, which is essential for developing effective therapies.
Reference
Core business
Scribe
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Edilytics
Cambridge, United States
B
1-10 Employees
2019
Key takeaway
Edilytics offers advanced precision genome editing solutions, highlighting CRISPResso2 as a trusted tool for analyzing gene editing experiments. This platform provides comprehensive data and user-friendly features, making it suitable for both academia and industry.
Reference
Core business
Edilytics | Precision Genome Editing Analysis
Metagenomi
Emeryville, United States
B
51-100 Employees
2018
Key takeaway
Metagenomi is developing potentially curative therapeutics through its metagenomics-powered gene editing toolbox, which utilizes undiscovered genetic material from natural environments. Their approach aims to create innovative genetic medicines by matching optimal gene editing tools to specific medical indications.
Reference
Core business
Curative Gene Editing Forged From Nature | Metagenomi
Metagenomi is transforming novel gene editing tools, mined from the world’s natural microbial environment, into life-saving genetic medicines.
Life Edit
Morrisville, United States
B
11-50 Employees
2017
Key takeaway
The company is focused on curing genetic diseases through innovative gene editing therapies. Their next-generation platform enables precise targeting of genomic sequences, allowing for the development of advanced treatments for challenging genetic disorders.
Reference
Core business
About
Emendo Biotherapeutics
New York, United States
B
11-50 Employees
2015
Key takeaway
EmendoBio is advancing CRISPR technology to address complex genetic diseases, enhancing traditional methods to unlock their full potential for human health. Their innovative approach focuses on understanding genetic diseases and developing customized editing strategies.
Reference
Core business
EmendoBio | Home | Unlocking the true potential of CRISPR
EmendoBio is boldly evolving traditional CRISPR solutions to make a positive impact on human health and previously incurable diseases.
Alliance Regenerative Medicine
Washington, United States
B
11-50 Employees
2009
Key takeaway
The company is focused on advancing gene therapies, which are a key component of regenerative medicine aimed at repairing and regenerating biological functions. Their commitment to innovative access and funding models highlights the transformative potential of these therapies in healthcare.
Reference
Product
Genome Editing - Alliance for Regenerative Medicine
Editas Medicine
Cambridge, United States
B
101-250 Employees
2013
Key takeaway
Editas Medicine is at the forefront of gene editing, utilizing CRISPR technology to develop innovative genomic medicines aimed at transforming the lives of individuals with serious diseases. They are actively researching both in vivo and ex vivo gene editing approaches to create effective treatments that target genetic disorders.
Reference
Core business
Editas Medicine
Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.
Tessera Therapeutics
Cambridge, United States
B
11-50 Employees
2018
Key takeaway
Tessera Therapeutics is pioneering Gene Writing™, a groundbreaking biotechnology that enables precise genomic alterations to cure diseases at their source. Their innovative approach focuses on tissue-targeted non-viral delivery technology, allowing for both small and large modifications to the human genome.
Reference
Core business
Tessera Therapeutics | A Flagship Pioneering Company
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing™, a new biotechnology designed to offer scientists and doctors the ability to make almost any change to the genome in any cell, thereby curing diseases at their source.
Technologies which have been searched by others and may be interesting for you:
The gene editing industry in the United States presents a dynamic landscape filled with various considerations. Regulatory frameworks play a crucial role, with organizations like the FDA and USDA overseeing the safety and efficacy of gene-edited products. It is essential to stay informed about evolving regulations, as they can significantly impact research, development, and commercialization efforts. Challenges such as ethical concerns and public perception also shape this industry, influencing funding and adoption rates. Opportunities abound, particularly in agriculture, medicine, and biotechnology, where gene editing techniques like CRISPR are being harnessed to enhance crop resilience and develop innovative therapies. The competitive landscape is marked by both established companies and startups, fostering a vibrant ecosystem of innovation and collaboration. Environmental concerns surrounding gene editing, especially in agriculture, warrant attention, as unintended consequences could arise from altered organisms. Furthermore, the global market relevance of gene editing is expanding, with international collaborations and research initiatives gaining momentum. Staying aware of these factors allows individuals and companies to navigate the complexities of the gene editing industry effectively while identifying potential pathways for growth and impact.
Some interesting numbers and facts about your company results for Gene Editing
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 2653 |
| Amount of suitable service providers | 2053 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2009 |
| Youngest suiting company | 2019 |
Some interesting questions that has been asked about the results you have just received for Gene Editing
What are related technologies to Gene Editing?
Based on our calculations related technologies to Gene Editing are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Gene Editing?
The most represented industries which are working in Gene Editing are Biotechnology, IT, Software and Services, Other, Healthcare, Medical
How does ensun find these Gene Editing Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
